Ravi N. Samy

Ravi N. Samy

Auto-generated profile, based on publicly available information

Ravi N. Samy

Department of Otolaryngology–Head and Neck Surgery, University of Cincinnati College of Medicine, Cincinnati, Ohio

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 October 2013 in The Laryngoscope
Verified
Journal Article
Closed access
PDF file
HSHwa J. Son
Hwa J. Son
AKAlexandre Karkas
Alexandre Karkas
PBPatrick Buchanan
Patrick Buchanan
JGJonathan P. Giurintano
Jonathan P. Giurintano
PTPhilip Theodosopoulos
Philip Theodosopoulos
RSRavi N. Samy
Ravi N. Samy

9 December 2014 in Cochlear Implants International
Verified
Journal Article
Closed access
RSRavi N. Samy
Ravi N. Samy
LHLisa Houston
Lisa Houston
MSMichael Scott
Michael Scott
DCDaniel I. Choo
Daniel I. Choo
JMJareen Meinzen-Derr
Jareen Meinzen-Derr
Objectives Few studies have addressed the benefits of cochlear implantation for the small group of patients with bilateral, end-stage Meniere's disease, or unilateral disease with contralateral hearing loss from another cause. Our retrospective study evaluates the effectiveness and post-operative performance in these Meniere's disease patients and discusses these findings relative to other post-lingually deafened adults. Methods Among 456 adults who received cochlear implants, we identified eight (1.7%) patients with Meniere's disease who met clinical indications for implantation and a control group of seven non-Meniere's patients of comparable age and deafness. Data gathered included demographics, auditory and vestibular symptoms pre-implantation, and clinical course after implantation, including audiometric scores (consonant-nucleus-consonant (CNC), hearing-in-noise testing (HINT), and AzBio score) and audiologic evaluations. Results Comparing the Meniere's and non-Meniere's patients, pre- to post-implant scores averaged 15 and 16%–57 and 76% for CNC; and 4.5 and 40.5%–78 and 81% for AzBio and/or HINT tests, respectively; scores between groups did not statistically differ. Of note, five of eight patients had 0% word recognition scores pre-operatively. Fluctuations in CI performance were seen in five patients with Meniere's disease but not for those without the disease. Conclusions Audiologic testing found a strong likelihood that CIs did benefit our subset of Meniere's patients with severe to profound sensorineural hearing loss. Fluctuations in hearing sensitivity (perhaps owing to physical changes relative to the implant array with the spiral ganglion neurons during an acute attack or changes in spiral ganglion neurons because of the hydropic state) can often be resolved by subsequent reprogramming.

1 May 2007 in The Laryngoscope
Verified
Journal Article
Closed access
PDF file
RSRavi N. Samy
Ravi N. Samy
KKKumaresh Krishnamoorthy
Kumaresh Krishnamoorthy
MPMyles L. Pensak
Myles L. Pensak

1 September 2021 in Medical Clinics of North America
Verified
Journal Article
Closed access
SSScott B. Shapiro
Scott B. Shapiro
KNKimberley S. Noij
Kimberley S. Noij
JNJames G. Naples
James G. Naples
RSRavi N. Samy
Ravi N. Samy

24 September 2015 in Otolaryngology–Head and Neck Surgery
Verified
Journal Article
Closed access
AAAshley L. Altman
Ashley L. Altman
JGJustin S. Golub
Justin S. Golub
MPMyles L. Pensak
Myles L. Pensak
RSRavi N. Samy
Ravi N. Samy

8 June 2018 in Operative Neurosurgery
Verified
Journal Article
Closed access
PDF file
JKJennifer A Kosty
Jennifer A Kosty
SSShawn M Stevens
Shawn M Stevens
YGYair M Gozal
Yair M Gozal
VDVincent A DiNapoli
Vincent A DiNapoli
SPSmruti K Patel
Smruti K Patel
RSRavi N Samy
Ravi N Samy
BACKGROUND: The middle cranial fossa (MCF) approach is a challenging surgical technique for the resection of small and intermediate sized, primarily intracanalicular, vestibular schwannomas (VS), with the goal of hearing preservation (HP). OBJECTIVE: To describe a decade-long, single institutional experience with the MCF approach for resection of VS. METHODS: This is a retrospective cohort study of 63 patients who underwent the MCF approach for resection of VS from 2006 to 2016. Audiometric data included pure-tone average (PTA), low-tone pure-tone average (LtPTA), word recognition score, and American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) hearing classification at presentation and follow-up. Patients with postoperative serviceable (AAO-HNS class A-B) and/or useful (AAO-HNS class A-C) hearing were compared to those without HP. Facial nerve function was assessed using the House–Brackmann scale. RESULTS: The mean age and duration of follow-up were 50 ± 13 yr and 21 ± 21 mo, respectively. The mean tumor size was 10 ± 4 mm. The serviceable and usable HP rates were 54% and 50%, respectively. Some residual hearing was preserved in 71% of patients. Large tumor size (P = .05), volume (P = .03), and extrameatal tumor extension (P = .03) were associated with poor audiometric outcomes. The presence of a fundal fluid cap (P = .01) was a favorable finding. At definitive testing, LtPTA was significantly better preserved than traditional PTA (P = .01). Facial nerve outcomes, tumor control rates, and durability of audiometric outcomes were excellent. 47% of patients pursued aural rehabilitation. CONCLUSION: In our series, the MCF approach for VS provided excellent rates of tumor and facial nerve function, with durable serviceable HP.